Iichiro Sugita

ORCID: 0000-0002-2311-2203
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Ophthalmology and Visual Impairment Studies
  • Intraocular Surgery and Lenses
  • Ocular Diseases and Behçet’s Syndrome
  • Corneal surgery and disorders
  • Protease and Inhibitor Mechanisms
  • Biomedical Research and Pathophysiology
  • Fibroblast Growth Factor Research
  • Neurological Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms
  • Retinal and Macular Surgery
  • Protein Kinase Regulation and GTPase Signaling
  • Advanced biosensing and bioanalysis techniques
  • Angiogenesis and VEGF in Cancer
  • Ocular Infections and Treatments
  • Proteoglycans and glycosaminoglycans research
  • Hormonal and reproductive studies
  • DNA Repair Mechanisms
  • Genetic and Kidney Cyst Diseases
  • DNA and Nucleic Acid Chemistry
  • Health disparities and outcomes
  • Health and Well-being Studies
  • Hedgehog Signaling Pathway Studies

Miyata Eye Hospital
2018-2022

Jikei University School of Medicine
2020

MedStar Harbor Hospital
2020

Keio University
2020

Chukyo Hospital
2020

Aichi Medical University
2009-2012

Kobe University
2004

Masahiko Shimura Shigehiko Kitano Nahoko Ogata Yoshinori Mitamura Hideyasu Oh and 95 more Haruka Ochi Shino Ohsawa Akito Hirakata Matthias Bolz Oliver Findl Andreas Pollreisz Martin Weger Vesselin Daskalov Aneta Misheva Iva Petkova Daniela Tosheva Guneva Petja Vassileva Pierre Loïc Cornut Jean François Korobelnik O. Lebreton Ramin Tadayoni Nicole Eter Nicolas Feltgen Carsten Framme Katrin Lorenz Georg Spital György Bátor András Seres Lajos Szalczer Edit Tóth‐Molnár Attila Vajas Balázs Varsányi Michaella Goldstein Jaime Levy Haia Morori-Katz Irit Rosenblatt Yoreh Barak Francesco Bandello Carlo Cagini Leonardo Mastropasqua Massimo Nicolò Maria Cristina Parravano Francesco Viola Akira Fukutomi Ken Hayashi Akito Hirakata Shigeru Honda Yasuhiro Ikeda Yasuki Ito Tsutomu Kawasaki Kazuhiro Kimura Genichiro Kishino Shigehiko Kitano Takatoshi Maeno Yoshinori Mitamura Tomoaki Murakami Kousuke Noda Akira Obana Nahoko Ogata Hideyasu Oh Osamu Sawada Akito Shimouchi Masahiko Shimura Masahiko Sugimoto Iichiro Sugita Hitoshi Takagi Kei Takayama Teruyo Tanabe Tsutomu Yasukawa Shigeo Yoshida Renata Cunha Matheus Rodrigues Garcia David Lozano Rechy Virgilio Morales Cantón Juan Ramirez Estudillo Karen Barraza C. Fernández Miguel A. Guzmán Silvio Lujan Maciej Gawęcki Ewa Herba Katarzyna Michalska‐Małecka Maria Muzyka−Woźniak Kamila Nester-Ostrowska Piotr Oleksy Bogumił Wowra Edward Wylęgała M V Budzinskaya Alexey N. Kulikov Т. В. Моругова Maria Hurcikova Marek Káčerik Blandína Lipková Santiago Abengoechea Alfredo Adán Pedro Amat Francisco Cabrera Carlos Eduardo Cava Alfredo García‐Layana Francisco Gomez Ulla José M. Ruíz-Moreno

10.1007/s10384-023-00979-8 article EN Japanese Journal of Ophthalmology 2023-03-10

Tumor necrosis factor-alpha (TNF-α) may disrupt the extracellular matrix components comprising blood-retinal barrier (BRB) in patients with posterior uveitis, such as Behçet's disease. We investigated changes mRNA expression levels of metalloproteinases (MMPs) and tissue inhibitors (TIMPs) human BRB cells presence TNF-α vitro examined effect infliximab addition.Cells were cultured or absence TNF-α, TNF-α-exposed treated without infliximab. measured MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, TIMP-2...

10.1089/jop.2010.0079 article EN Journal of Ocular Pharmacology and Therapeutics 2010-11-05

To evaluate the safety and efficacy of a new toric intraocular lens (IOL) with anchor-wing haptics.The IOL haptics (NS60YT, NIDEK Co., Ltd.) was implanted in eligible patients age-related cataracts preoperative corneal astigmatism 1.0 D or greater at university hospital two private hospitals Japan. The following cylinder powers were evaluated: 1.50 (NS60YT3), 2.25 (NS60YT4), 3.00 (NS60YT5) 4.50 (NS60YT7). All assessed out to 12 months postoperatively. primary endpoint visual acuity (VA)...

10.1186/s12886-021-02240-7 article EN cc-by BMC Ophthalmology 2022-01-15

Abstract Background and Objective We investigated the levels of matrix metalloproteinase‐2 (MMP‐2), which has been implicated in various vitreoretinal diseases, retina after laser photocoagulation (LPC). Materials Methods The time course MMP‐2 expression 2‐day‐old chicken retinas before 6 hours, 12 1 day, 2 days, 4 8 16 32 days LPC was determined by real‐time PCR gelatin zymography. basal level vitreous also measured localization examined immunohistochemistry. mRNA fluorescent situ...

10.1002/lsm.20931 article EN Lasers in Surgery and Medicine 2010-06-25

AbstractThe accumulation of DNA damages by environmental stresses is represented the steady state level single strand breaks (SSBs) and double (DSBs). Terminal deoxynucleotidyl transferase (TdT) mediated end labeling suitable in detecting DSBs, but unsuitable for SSBs due to its catalyzing characteristics. However, sensitivity TdT detect may be significantly improved first denaturing strands expose all nicks as potential substrates TdT. By coupling denaturation slot blot southern...

10.1080/1071576042000209817 article EN Free Radical Research 2004-04-21

<b><i>Background:</i></b> Differences in the efficacy of bevacizumab, an antivascular endothelial growth factor (VEGF) agent, against retinopathy with neovascularization when injected into vitreous cavity vitrectomized and nonvitrectomized eyes suggests involvement hyaluronan, a major component body. This study aimed to compare affinities hyaluronan for anti-VEGF agents vitro. <b><i>Methods:</i></b> We examined 3 (bevacizumab, pegaptanib...

10.1159/000342975 article EN Ophthalmic Research 2012-10-30

Purpose: Bardet-Biedl Syndrome (BBS) is an autosomal recessive systemic disorder characterized by retinitis pigmentosa, polydactyly, obesity, intellectual disability, renal impairments, and hypogonadism. The purpose of this study was to determine the ocular characteristics a boy with BBS caused novel homozygous variant in ARL6 (alternative named BBS3 ) gene who had been originally diagnosed punctata albescens. Methods: This observational case study. patient underwent ophthalmological...

10.1097/md.0000000000032161 article EN cc-by-nc Medicine 2022-12-16

Abstract Background: To evaluate the safety and efficacy of a new toric intraocular lens (IOL) with anchor-wing haptics. Methods: The IOL haptics (NS60YT, NIDEK Co., Ltd.) was implanted in eligible patients age-related cataracts preoperative corneal astigmatism 1.0 D or greater at one university hospital two private hospitals Japan. Four cylinder powers were evaluated as follows: 1.50 (NS60YT3), 2.25 (NS60YT4), 3.00 (NS60YT5) 4.50 (NS60YT7). All assessed out to 12 months postoperatively....

10.21203/rs.3.rs-55494/v1 preprint EN cc-by Research Square (Research Square) 2020-08-20

Abstract Background: To evaluate the safety and efficacy of a new toric intraocular lens (IOL) with anchor-wing haptics. Methods: The IOL haptics (NS60YT, NIDEK Co., Ltd.) was implanted in eligible patients age-related cataracts preoperative corneal astigmatism 1.0 D or greater at university hospital two private hospitals Japan. following cylinder powers were evaluated: 1.50 (NS60YT3), 2.25 (NS60YT4), 3.00 (NS60YT5) 4.50 (NS60YT7). All assessed out to 12 months postoperatively. primary...

10.21203/rs.3.rs-55494/v2 preprint EN cc-by Research Square (Research Square) 2020-11-11
Coming Soon ...